Diagnostic test for ovarian cancer

Thursday, 01 January, 2009 | Supplied by: Manalto Inc

The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.

The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.

Results are available within a fortnight.

Online: www.healthlinx.com.au
Phone: 03 9208 4200

Invent Biotechnologies Minute Single Cell Nuclei Kits

The Invent Biotechnologies Minute Single Cell Nuclei Kits use proprietary spin column-based...

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces is a magnetic bead-based solution...

Enzo Life Sciences Histamine ELISA Kit

The Enzo Life Sciences Histamine ELISA Kit is engineered to enable the ultra-sensitive detection...

Content from other channels on our network

Why cyber resilience is now a patient safety KPI

Woman fined for falsely claiming to be a psychologist in ACT Supreme Court

Training suite simulates hospital, aged care and community health settings

National standards for pain management education now available

Daniel Wyner appointed Lumary CEO

Gentler processing could be key to better tasting honey

Low-cal sweetener under development at UQ

$10m funding to help manufacturers decarbonise industrial process

Sydney University signs agrifood innovation agreement with FAO

interpack 2029 will have a new runtime

Analysis shows AI's water use demands immediate action

New method recycles mixed plastic packaging sans chemicals

Engineers extract lithium using low-water alternative

Microbubbles remove microplastics from wastewater

Partnership boosts bio-based graphite material deployment